BIT 10.0% 3.3¢ biotron limited

Ann: Letter to Shareholders , page-7

  1. 765 Posts.
    I like the look of the newsletter.If HCV trials are successful the market will rerate her accordingly...following this the bluesky valuations will come from her HIV potential over and above.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.